https://www.urotoday.com/recent-abstracts/urologic-oncology/prostate-cancer/102618-twenty-year-risk-of-prostate-cancer-death-by-midlife-prostate-specific-antigen-and-a-panel-of-four-kallikrein-markers-in-a-large-population-based-cohort-of-healthy-men.html
Citando:
"A prespecified statistical model based on four kallikrein markers (commercially available as the 4Kscore) reclassified many men with modestly elevated PSA, to have a low long-term risk of prostate cancer death. Men with elevated PSA but low scores from the four-kallikrein panel can be monitored rather than being subject to biopsy.
Men with elevated prostate-specific antigen (PSA) are often referred for prostate biopsy. However, men with elevated PSA but low scores from the four-kallikrein panel can be monitored rather than being subject to biopsy."